Cytotoxic activity and HDAC inhibition [IC50 (μM)] of compounds 1-20 and vorinostat against human colon cancer (HCT116), human cervical (HeLa), lung (A549) and ovarian cancer (A2780) cell lines. Here, HDAC9 is linked to malignant colon neoplasm.